Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment
Completed
Conditions studied: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
In brief
This study is being done to look at the electrical activity of the heart. This study will help decide whether taking recordings for a 24-hour period gives more useful information than recording it for a few seconds in a doctor's office. The study will compare 24 hour electrocardiogram (ECG) results of patients taking thioridazine (Mellaril) to those of other patients taking different medications that took part in another study.
Key facts
- Study ID
- NCT00538122
- Run by
- Vanderbilt University
- People needed
- 12
- Starts
- 2007-07-01
- Expected to finish
- 2008-09-01
- Last updated by the study team
- 2009-01-27
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must be male or female, age 18-65
- Patients must have a definitive diagnosis by DSM-IV criteria of schizophrenia, bipolar or schizoaffective disorder.
- Patients can be receiving inpatient or outpatient treatment at time of enrollment.
- Patients must have been treated with (Mellaril) thioridazine, (Risperdal) risperidone or (Seroquel) quetiapine at least three months at time of enrollment.
- Patients must be able to provide written informed consent
You may not qualify if…
- Patients with a primary diagnosis other than schizophrenia, schizoaffective or bipolar disorder
- Patients who are currently taking other medications that have been shown to prolong the QTC, including tricyclic antidepressants, fluoroquinolones or antiarrythmics.
- Patients unable to provide written informed consent.
Where it is running
- Vanderbilt Psychiatric Hospital — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.